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We assessed exposure to dioxin-like compounds using chemical and bioassay analysis in different
matrices in afemale population. Atotal of106 serumand 9 follicular fluid samples were collected
from infertile women attending Centers for Reproductive Medicine in Belgium from 1996 to
1998. Majorpolychlorinated biphenyl (PCB) congeners were quantified bychemical analysisusing
gas chromatography with electron-capture detection, and the chemical-activated luciferase gene
expression (CALUX) bioassaywas used to determine the total dioxin-like toxic equivalence (TEQ)
ofmixu ofpolyhalogenated aromatic hydrocarbons present in body fluids, such as serum and
follicular fluid. To the best ofourknowledge, this is the first investigation to determine TEQvaI-
ues bythe CALUXbioassayin follicular fluid. The TEQlevels in both matrices arewell corrdated
(r= 0.83,p = 0.02). As the chemical and bioassay analysis exected in this studydo not cover the
same span ofpolyhalogenated aromatichydrocarbons, we did notexpect totally correlated results.
Moreover, the sampleworkup and quantification ofthe analytes diferedcompletely. Nonetheless,
the TEQvalues in human extracts correlated well with the sum of four major PCB congeners
chemically determined in both serum and follicular fluid. These results indicate that the CALUX
bioassay mayserve as asimple, relativelyinexpensive prescreening tool for exposure assessment in
epidemiologic surveys. Keywork CALUX bioassay, chemical-activted luciferase gene expression
bioassay, dioxin-like compounds, follicular fluid, polychlorinated biphenyls (PCBs), serum, toxic
equivalences. EnvirnHealt Pmnpect108:553-557 (2000). [Online 2 May2000]
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Polyhalogenated aromatic hydrocarbons
(PHAHs) represent a class of widespread
environmental contaminants including poly-
chlorinated dibenzo-p-dioxins (PCDDs),
polychlorinated dibenzofurans (PCDFs), and
polychlorinated biphenyls (PCBs). Due to
their low biodegradation and lipid solubility,
these ubiquitous pollutants bioaccumulate
throughout the food chain and may pose a
health risk to both animals and humans (1).
In fact, several epidemiologic studies indicate
subtle changes in neurobehavioral and
endocrine parameters in infants in relation to
relatively high background levels ofPHAHs,
which can occur in industrialized countries in
theWestern World (2,3).
Since 1970, body burden measurements
for chlorinated contaminants in humans have
been determined in blood, follicular fluid,
human milk, and adipose tissue (4,5).
Current techniques for detection and quan-
tification ofPHAHs involve costly and time-
consuming traditional chemical analysis by
gas chromatography with mass spectrometry
in selected ion monitoring or electron-capture
detection mode. Gas chromatographyanalysis
provides information about the presence and
concentration of known isomers and con-
geners, but no information about the biologic
effects ofthesecomplex mixtures (6).
Extensive experimental studies have
revealed that most toxic actions induced by
dioxin-like compounds are mediated via the
aryl hydrocarbon receptor (AhR) signal trans-
duction pathway (7,8). Quantification ofthe
toxic potency of the whole mixture of com-
pounds acting via the AhR pathway would
strengthen the causal relationship between
observed adverse effect and the presence of
PHAHs as a group (91. For this purpose, the
dioxin-like toxic equivalency factor (TEF)
conceptwas introduced bySafe (10), allowing
conversion of the PHAH chemical data set
into the AhR-related toxic potency of the
mixture ofPHAHs. PCB congeners that can
assume a coplanar configuration (non-ortho,
and to alesser extent some mono-orthosubsti-
tuted congeners) also have a high affinity to
the AhR and with binding initiate biologic
actions and toxicity similar to 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD; the most
toxic dioxin). Concentrations of individual
PHAHs are multiplied by their respective
TEF values and added together to give the
dioxin-like total toxic equivalency (TEQ)
value (7,11). It has recently been shown that
the contribution of dioxin-like PCBs to the
total TEQvalue in human matrices is almost
equal to the PCDDs/PCDFs fraction (12,13).
Recently, bioassays have been developed
that can measure the total TEQ value of
complex mixtures directly, without the need
for extensive cleanup and chemical analysis
procedures. One ofthe novel in vitro reporter
gene assays, the chemical-activated luciferase
gene expression (CALUX) bioassay, is based
on AhR-mediated firefly (Photinus pyralis)
luciferase expression in genetically modified
cell lines (6,14). A vector containing the
luciferase gene under transcriptional control
of dioxin-responsive elements was stably
transfected into a number of cell lines,
including the rat H4IIE hepatoma cell line.
The CALUX bioassay has recently been
adapted and validated in blood plasma (9)
and bovine milk (15).
In this study, we assessed exposure to
PHAHs using a combination of chemical
and bioassay analysis in a selected female sub-
population. Major PCB congeners in serum
and follicular fluid were quantified by chemi-
cal analysis using gas chromatography with
electron-capture detection (GC-ECD) and
TEQvalues in blood serum were determined
using the CALUX bioassay. Four PCB con-
geners, IUPAC (International Union ofPure
and Applied Chemistry) numbers 118, 138,
153, and 180, were selected because many
European government and regulatory bodies
use them as marker compounds to monitor
occurrence and distribution. In human
matrices, the three latter congeners make up
55% of the total PCBs (16). The congeners
under chemical analysis are non-dioxin-like
(only PCB-118 has a TEF-value of 0.0001)
(17). The physicochemical characteristics and
environmental behavior of individual PCB
congeners are remarkably similar and have
been found as complex mixtures in almost all
compartments of the biosphere, including
animal and human tissues and body fluids
(3). Hence, we are exposed to a broad spec-
trum of PCB congeners with (non)-dioxin-
like capacities.
To the best ofour knowledge, this is the
first investigation that aimed to determine
TEQ values in follicular fluid. We decided
to select infertile women as a study popula-
tion. Some ofthese patients were candidates
for donation of follicular fluid, as they were
undergoing in vitro fertilization (IVF)
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treatment. In addition, both analytical tools
were applied in a case-control study to assess
the impact ofdioxins and related compounds
on the occurrence of endometriosis. The
main finding of this survey constituted the
association ofexposure to dioxin toxic equiva-
lences with the risk for endometriosis [crude
odds ratio (OR) = 4.3]. After adjusting for
body mass index and alcohol consumption,
the risk increased slightly to OR = 4.6. There
was no confounding by age, ovulatory dys-
functions, caffeine intake, or smoking. On
the other hand, there was no evidence for
impact ofexposure to four major PCB con-
geners on the occurrence of endometriosis
(ORs ranging from 1.007 to 1.026, none of
them significant). Therefore, the reported
association between exposure to dioxins and
related compounds and endometriosis cannot
be confounded by the exposure to major
PCBs (18).
Materials and Methods
Subjects and sampling. Subjects were all
infertile females visiting a fertility unit. A
couple is defined as "infertile" when pregnan-
cy has not been achieved after 1 year of
unprotected sexual intercourse. Sampling of
serum and follicular fluid was performed at
the Centers for Reproductive Medicine of
the University Hospitals ofAntwerp (UZA),
Ghent (UZG), and Leuven (UZL). This
study has been accepted by all ethical com-
mittees (protocol nos. 96/44/107, 97/100,
and ML 536 for UZA, UZG, and UZL,
respectively). All patients acknowledged their
participation by signing an informed con-
sent. The mean age ofthe women was 31.9 ±
4.0 years (range 24-42).
We collected 25 ml blood per patient in a
vacuum system tube and centrifuged it (15
min, 2,000,g) within 24 hr after collection. All
serum sampleswere stored at -20°C until ana-
lyzed. Nine patients receiving IVF treatment
were also candidates for donation offollicular
aspirates obtained for investigation. Follicles
were aspirated under ultrasound-guided trans-
vaginal puncture after pituitary desensitiza-
tion with Buserilin nasal spray (800 Fug daily;
Suprefact, Hoechtst, Belgium) followed by
human menopausal gonadotropin (hMG),
only 2 ampules of 75 U daily until at least
two follicles reached a diameter of20 mm.
The puncture was performed 36 hr after an
ovulatory trigger with 10,000 IU human
chorionic gonadotropin (hCG) intramuscu-
larly. After removal ofthe oocytes, all follicle
fluids (free ofblood contamination and gran-
ulosa cells) were pooled per patient and stored
at-200C until further analysis.
Chemicals andreagents. All solvents used
for chemical analysis [pesticide grade (p.a.)]
were purchased from E. Merck (Darmstadt,
Germany). Four marker PCBs (IUPAC nos.
118, 138, 153, and 180) were a standard
mixture from J.T. Baker (Deventer, The
Netherlands) at a concentration of 10 ng/pL
in isooctane. A standard mixture solution
containing all compounds under investiga-
tion was prepared in n-hexane. The 13C12-
labeled CB-110 and CB-149 were obtained
from Cambridge Isotope Laboratories
(Woburn, MA).
For CALUX analysis, isopropanol, diethyl
ether, and isooctane were of p.a. grade
(Merck). Hexane was of HPLC quality.
Ultraclean DMSO was purchased from
Janssen (Beerse, Belgium). Sulfuric acid (AR,
J.T. Baker) was washed with hexane before
use in a silica gel 60 (70-230 mesh, ASTM;
Merck) column with anhydrous dried sodium
sulfate (p.a., Merck).
Chemical analysis by GC-ECD.
Complete details of the solid-phase disk
extraction are described and evaluated else-
where (19). The method was shown to be
consistent at three fortification levels.
Reproducibility, in terms ofrelative standard
deviation, was < 13% for all tested PCB con-
geners at the lowest fortification level (625 pg
of each congener/g serum). Mean recovery
for '3C12 CB-110 (surrogate standard) was
85.0 ± 6.6%. A brief description of the
method is given below. The sample prepara-
tion involved disruption of protein binding
in an ultrasonic bath using formic acid (1:1,
v/v), extraction, and concentration of ana-
lytes using Empore C18 SPE disk cartridges
(3M, St. Paul, MN). A mixture of ethyl
acetate and hexane was used for elution.
Further cleanup of lipid interferences was
accomplished using a sulfuric acid wash of
the eluate. After concentration under a gentle
nitrogen stream, we injected 2 pL per extract
in splitless mode onto a GC-pECD system
(HP 6890; PaloAlto, CA) by an autosampler
(HP 7673). A fused silica DB-XLB capillary
column (J&W Scientific, Folsom, CA) of60
m X 0.25 mm i.d. x 0.25 pm film thickness
was used with the following temperature pro-
gram: initial 65°C held for 2 min, then to
220°C at a rate of 50°C/min, 1.5°C/min to
255°C, and then 20°C/min to 290°C, and
held for 5 min. The carrier gas was hydrogen
at a constant pressure of 135 kPa. The
pECD temperature was kept at 320°C, using
argon-methane (95 + 5) makeup gas at a
flow rate of20 mL/min.
CALUX bioassay. The extraction and
cleanup procedure was performed as
described in detail by Murk et al. (9). The
method involves esssentially n-hexane extrac-
tion of blood serum or follicular fluid
aliquots (1-1.5 mL) and removal of acid-
labile matrix components by passage
through a silica column containing 33%
(w/w) concentrated H2S04. This extract was
quantitatively transferred to a tapered vial,
evaporated, and diluted in DMSO for
CALUX measurement in 96-well plates
using H4IIE.Luc cells.
Rat H4IIE hepatoma (H4L1.1c4)
cells stably transfected with an AhR-con-
trolled luciferase reporter gene construct
(pGudlucl.1) were grown to confluence in
96-well view plates and exposed in triplicate
to the PHAH samples and TCDD standards
for 24 hr, using DMSO (0.5% v/v) as a vehi-
cle. After removal of the medium, cells were
washed twice with phosphate-buffered saline
(Oxoid, Hampshire, UK). The cells were har-
vested in 75 jL cell lysis reagent and cen-
trifuged, and the supernatant was frozen at
-80°C. For measurement ofluciferase activity,
the supernatants were thawed on ice, 20-gL
aliquots were pipetted into a 96-well micro-
titer plate, and 100 jL luciferin assay mix at
room temperature was added. After thorough
mixing, we measured the light production in
a Luminoskan RS Luminometer (Labsystems,
Helsinki, Finland).
Lipid determination. Lipids of serum
and follicular fluid were determined enzy-
matically. Concentrations of triglycerides,
cholesterol (free and cholesterol esters), and
phospholipids were determined in duplicate
by quantitative enzymatic determination
using commercially available reagents from
Elitech Diagnostics (Sees, France). We cal-
culated the total serum lipid concentration
by adding the amounts oftriglycerides, cho-
lesterol, and phospholipids. The total mean
serum lipid concentration by enzymatic
determination was 507 ± 122 mg/dL (n =
106, range 214-1,059). For the follicular
fluids, the cholesterol and triglycerides could
not be quantified enzymatically. Hence, the
phospholipid contents were used for further
calculations. The mean lipid concentration
for follicular fluids was 49.2 ± 15.8 mg/dL
(n = 9, range 23-72).
CalculationsofCALUXTEQsandstatis-
tics. We calculated CALUX-based TEQs by
comparing the luciferase activity induced by
the sample against a dose-response curve
generated from TCDD concentration stan-
dards analyzed simultaneously. The standard
curve was fitted (one-site ligand fit) using
SlideWrite 6.00 (Advanced Graphics Soft-
ware Inc., Encinitas, CA), and the CALUX
TEQ value ofan unknown sample was inter-
polated on this curve. A full dose-response
curve was presented previously (20). Mean
values were calculated from the individual
TEQ/g fat values thus obtained from each of
three replicates.
All statistical calculations were performed
using Statistica (version 5; StatSoft, Tulsa,
OK). Means, SDs, and medians are reported
in terms oforiginal distributions. All thevari-
ables were tested for normality by Shapiro-
Wilk's W-test. We calculated associations
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between independent variables using
Pearson correlation coefficients. A finding
was considered statistically significant if its
P-value was < 0.05.
Results
Residue levels in serum andfollicularfluid.
PHAH body burdens were determined in
human serum and follicular fluid obtained
from infertile women attending one of the
collaborating Centers for Reproductive
Medicine. A summary ofPCB congener lev-
els, achieved by chemical analysis, is listed in
Table 1. The arithmetic means ± SDs and
medians, together with the number ofsam-
ples containing quantifiable amounts, are
presented. Missing data derive from peak
interferences in the gas chromatogram. The
values indicate that the concentrations for
individual PCB congeners are higher in fol-
licular fluid, partly due to the lower fat
content of this fluid. If the results are
expressed on a whole-weight basis (data not
shown), the numbers fall in the same range
forboth matrices.
To evaluate how accurately the serum
concentrations would predict the follicular
fluid levels, correlations between the values
were computed to determine their strength
of association for each congener. Except for
PCB-118, the numbers in Table 1 reveal
strong and statistically significant correlations
for the individual congeners and the sum of
PCBs in both matrices.
To compare the PCB accumulation pat-
tern in follicular fluid and serum, the total
sum ofall four congeners has been taken as
100%, and this distribution is presented in
Figure 1. Follicular fluid and serum show
opposite patterns ofaccumulation for PCB-
153 and PCB-180. PCB-153 is the major
congener in serum, in contrast to the follicu-
lar fluid, where PCB-180 is considerably
more concentrated.
TEQ values measured through the
CALUX bioassay are summarized in Table
2. The results of14 serumsamples and 1 fol-
licular fluid sample were below the limit of
detection (32 fg TEQ/well). The mean TEQ
level in follicular fluid is considerably higher
than the mean serum TEQvalue (257.9 ±
225.0 and 46.8 ± 43.8 pg TEQ/g lipid,
respectively, in follicular fluid and serum),
partly due to the lower fat content ofthe fol-
licular fluid. However, the correlation
between TEQ levels in serum and follicular
fluid is statistically significant (n = 7, r= 0.83,
p = 0.02). The high coefficients ofvariance
are partlydue to the small numbers (follicular
fluid and plasma) and partly due to a wide
variation of contamination in these selected
subpopulations.
Comparison between CALUX TEQ val-
ues andPCB levels. The Pearson correlation
coefficients between the CALUXTEQvalues
and the nonplanar PCB congeners within the
serum samples are all highly significant and
varyfrom 0.34 to 0.43 (Table 3). In addition,
the correlation coefficients in follicular fluid
are up to 0.74 for the PCB congeners. The
correlation is statistically significant for PCB-
138. The distributions of the sum of PCB
congeners and TEQ levels in serum are
shown in Figure 2A and 2B, respectively.
Both skew distributions show a median level
lowerthanthemean concentration.
Comparison ofTEQ levels with other
CALUXdata. In 1989, a collaborative study
was started in The Netherlands (Dutch
Mother's MilkCohort Study); this studycon-
cerning the potential effects of PCBs and
dioxins on the growth and development of
newborns (21-23) was supported by the
Dutch Toxicology Research Promotion
Programme and the Health Research
Stimulation Programme. The CALUX data
ofthe present investigation can be compared
with plasmasamples, derived from the Dutch
Mother's Milk Cohort Study, determined
under the same analytical conditions. These
12 plasma samples were taken between 1990
and 1992 from nursing mothers; therefore,
the patients' ages are presumably comparable.
Thevalues inTable 2 indicate that the Dutch
women sampled approximately 6 years before
this investigation had a considerably higher
Table 1. PCB congener levels determined by GC-ECD in Belgian female bodyfluids, 1996-1998.
PCB-118 PCB-138 PCB-153 PCB-180 Sum PCBsa
Serum (n=106)
No. positiveb 101 98 102 101 97
Mean ±SD 27.7 ± 16.2 69.9 ± 30.7 94.5 ± 45.2 72.0 ± 35.7 263.5±115.6
Median 25 64.7 85.3 62.7 245.7
Follicularfluid(n=9)
No. positive 9 9 9 9 9
Mean ±SD 149.4 ±77.1 329.7 ± 223.5 352.4 ± 199.6 406.5 ± 235.9 1,238.0 ± 694.0
Median 134.2 242.8 346.9 428.9 1,288.6
Correlation, serum-follicular fluid
No. samples 9 9 9 9 9
Correlation 0.40 0.66 0.71 0.73 0.71
(p-Value) 0.28 0.05 0.03 0.03 0.03
All values are expressed in ng/g lipid.
*Sum PCBs isthe sum ofthe four congeners. bLower numbers indicate missing data due to interferences.
level of exposure (mean 103.7 ± 51.5 pg
TEQ/glipid) than the Belgian female patients
recruited for the present survey (mean 46.8 ±
43.8 pg TEQ/g lipid). The lipid contents of
the samples ofthe Dutch survey were deter-
mined gravimetically, whereas the recent
CALUX results are all based on enzymatic
lipiddeterminations.
Discussion
Currently, most toxicologic risk assessments
are based on chemical residue analysis corre-
lating them with determinations of toxic
effects in wildlife species and humans. Even if
the toxicities ofall compounds were known,
it would not be possible, on the basis of a
chemical analysis alone, to say anything defi-
nite about how the pollutants in the sample
affect living organisms (24). Because dioxin-
like compounds normally exist in environ-
mental and biologic samples as complex
mixtures ofcongeners, the concept ofTEQs
has been introduced to simplify risk assess-
ment and regulatory control. In applying this
concept, relative toxicities ofdioxin-like com-
pounds in relation to TCDD (i.e., TEFs) are
determined based on in vitroand in vivostud-
ies (11). Previously, TEQs were determined
using gas chromatography with high-resolu-
tion mass spectrometry (GC-HRMS) for the
chemical analysis. Although this approach is
an improvement over simple chemical analy-
sis, the often small concentrations ofindivid-
ual congeners, the presence of unknown or
not routinely measured AhR-active sub-
stances, the lack of TEF values for several
PHAHs, and the possible additive and/or
antagonistic interactions between PHAHs
(1,11) are drawbacks to this GC-HRMS
analysis (9). These pitfalls are overcome by
the immediate measurement of the biologic
response instead of determining the culprit
compounds using chemical analysis. This
alternative technique using the CALUX
bioassay determines the TEQvalue as a sum
of the synergistic, additive, or antagonistic
interactions ofallAhR-active compounds.
In this survey, exposure assessment to
dioxin-like compounds was performed using
gas chromatography to quantify PCB con-
gener levels and the CALUX bioassay, which
determines the total dioxin-like toxic equiva-
lence of mixtures of PHAHs as present in
PCB-l18 PCB-138 PCB-153 PCB-180
Figure 1. Distribution pattern of PCB congeners in
follicular fluid and serum (n = 9) according to their
fractions. The concentration of the sum of PCBs
was set at 100%.
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bodyfluids such as serum and follicular fluid.
Unfortunately, the bioassay results to identify
the culprit dioxin-like compounds could not
be confirmed by chemical analysis. Due to
the lowlevels in biologic matrices, the chemi-
cal analysis ofdioxins and related compounds
requires a multistage cleanup and sensitive
and selective detectors (high resolution or
negative ion chemical ionization mass spec-
trometry). In addition, the large amounts of
human sample needed (50 mL serum) for
quantification were unacceptable in the cur-
rent study for ethical reasons. In contrast, the
sample amount needed for the CALUX assay
was limited to 1.5 mL/patient.
Because the chemical and bioassay analy-
ses presented here do not cover the same
range of PHAHs, we do not expect totally
correlated results. Moreover, the sample
workup (extraction and further purification)
and quantification ofthe analytes were com-
pletely different. Nonetheless, the TEQ val-
ues in human extracts correlated well with
the sum offour major PCB congeners chem-
ically determined in both matrices (Table 3).
These results indicate that the CALUXbioas-
say may serve as a simple, relatively inexpen-
sive prescreening tool to be used for exposure
assessment in epidemiologic surveys, whereas
current epidemiologic surveys are almost
exdusively based on chemical analysis. How-
ever, samples that induce a higher CALUX
response than the limitvalues should undergo
chemical analysis to confirm and identify the
compounds responsible.
We previously evaluated the relationship
between gravimetric and enzymatic lipid
determinations (25). The correlation for
serum lipids was strong and statistically sig-
nificant (r = 0.75, n = 96, p < 0.001); how-
ever, gravimetric lipid determinations differ
greatly between laboratories, depending on
the extraction conditions and solvents used.
Moreover, the extracts can contain other
extractable material aswell ($).
PCB-153 and PCB-180 do not possess
two unsubstituted carbohydrons next to
each other and are therefore highly persistent
in the environment. In the same way, highly
chlorinated biphenyls containing a 2,3,4-
trichlorophenyl group (such as PCB-138)
can resist metabolic breakdown and so accu-
mulate rapidly in body tissues (26). We pre-
viously reported that serum concentrations
of major PCB congeners are reliable predic-
tors offollicular fluid levels (27). Except for
PCB-118, the major PCB congener correla-
tions were strong and statistically significant.
Table 2. CALUX TEQ values in Belgian female body fluids, as compared to previous CALUX data analyzed
underthe same analytical conditions.
Belgium8 The Netherlandsb
Serum Follicularfluid Plasma
(n= 106) (n=8) (n= 12)
No. above detection limitc 92 7 12
Mean ±SD 46.8 ± 43.8 257.9 ± 225.0 103.7 ± 51.5
Median 37.4 246.5 100.1
All values are expressed in pgTEO/g lipid.
'This study (1996-1998); lipids enzymatically determined. bDutch Mother's Milk Cohort Study(1990-1992); lipids gravimet-
ricallydetermined. cDetection limit 32fg TEO/well.
Table 3. Pearson correlation coefficients between PCB congener levels in body fluids (ng/g lipid) and
CALUXTEQvalues (pg TEQ/g lipid).
Serum Follicularfluid
No. r p-Value No. r p-Value
PCB-118 100 0.35 <0.001 8 -0.23 NS
PCB-138 97 0.39 <0.001 8 0.74 0.037
PCB-153 101 0.38 <0.001 8 0.57 NS
PCB-180 100 0.34 <0.001 8 0.57 NS
Sum PCBsa 96 0.43 <0.001 8 0.58 NS
NS, notsignificant.
'Sum PCBs isthe sum ofthe four congeners.
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Figure 2. Distribution of (A) the sum of four PCB congeners and (B) CALUX TEQ levels in serum (n = 106).
In (8), 14 observations are notshown duetoTEQ levels belowthe detection limit.
All these results were expressed on a whole-
weight basis. Focusing on our recent data
(Table 1), the previous associations can be
confirmed. The latter correlations are even
stronger and statistically significant (except
for PCB-1 18), suggesting that expressing
results on a lipid basis improves comparison
ofdifferent biologic matrices.
The different mode oforigin and the dif-
ferent lipid contents probably lead to selective
accumulation in different body fluids (28).
When focusing on the PCB accumulation
pattern, the accumulation ofindividual PCBs
varied only with respect to the number and
positions ofthe chlorine substituents. In our
small sample (n = 9), follicular fluid and
serum show opposite patterns ofaccumula-
tion for PCB-153 and PCB-180. These data
support the findings ofSchlebusch et al. (29),
suggesting that the proportion of the more
highly chlorinated PCBs may be increased in
body compartments associated with repro-
duction. Certainly, different accumulation
patterns can affect the toxic potential of the
PCBs. If different matrices show different
congener distribution, this may have an
impact on the toxic outcome. These prelimi-
nary results may partly explain the somewhat
higher TEQvalues in follicular fluid as com-
pared to serum TEQs.
Focusing on the comparison between the
recent investigation and data from the Dutch
Mother's Milk Cohort Study, Dutch women
sampled 6 years earlier were considerably
more exposed to dioxin-like compounds.
Recent Dutch CALUXdata (30) reveal TEQ
levels in the same range as the recent Belgian
investigation. Similar declining trends have
been reported for Germany and the United
Kingdom (12.
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